Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2015
Global Markets Direct’s, ‘Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2015’, provides an overview of the Nerviano Medical Sciences S.r.l.’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Nerviano Medical Sciences S.r.l.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
- The report provides brief overview of Nerviano Medical Sciences S.r.l. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Nerviano Medical Sciences S.r.l.’s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Nerviano Medical Sciences S.r.l.’s pipeline products
Reasons to buy
- Evaluate Nerviano Medical Sciences S.r.l.’s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Nerviano Medical Sciences S.r.l. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Nerviano Medical Sciences S.r.l.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Nerviano Medical Sciences S.r.l. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nerviano Medical Sciences S.r.l. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Nerviano Medical Sciences S.r.l. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Our reports have been used by over 10K customers, including:
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from...
107 pages •
By Infiniti Research Limited
• Nov 2018
About Ceramic Sanitary Ware Sanitary wares comprise of bathroom equipment primarily used for defecation and other hygiene applications. The durability, glossy surface, and easy cleaning properties makes ceramics the most extensively used material in sanitary ware applications. Technavio’s analysts forecast the...
120 pages •
By Infiniti Research Limited
• Nov 2018
119 pages, November 2018 About this market With the increasing privatization in healthcare sector, there is a growing demand for refurbished medical devices. The privatization in the healthcare sector is rapidly increasing due to the inability of governments to invest efficiently in the healthcare sector and due...
This IDC study provides manufacturers and retailers with the top 10 predictions and underlying drivers that we expect to impact manufacturers' IT investments in the supply chain in 2019 and beyond.According to Simon Ellis, program vice president, global Supply Chain Strategies, "The supply chain continues on its journey of almost unparalleled...
This IDC study presents the top 10 predictions for the 2019 worldwide security products and services market."We see this as a complicated time for IT and security practitioners as the complexity of networks is changing, the adversary becomes better equipped, protection of identity is requisite, and compliance becomes enforceable," said Christina...